Neonc Technologies, Inc.

This study is testing an inhaled therapy called NEO100 for people with aggressive, recurrent meningioma brain tumors that have returned or grown after surgery and radiation. The therapy is a plant-based compound sniffed through the nose four times a day, aiming to deliver treatme…

This study is testing a new oral medication called NEO212 for adults with specific aggressive brain tumors (like glioblastoma) or brain metastases from other cancers. The main goals are to find a safe and effective dose, see how the body processes the drug, and check if it can he…

This study is testing the safety and early effectiveness of an experimental nasal spray called NEO100 for adults with aggressive brain tumors (Grade III or IV gliomas) that have grown back after standard treatment. The spray aims to deliver treatment directly to the brain to try …